HK Inno N Corp logo

HK Inno N Corp (195940)

Market Closed
10 Aug, 06:30
KOSDAQ KOSDAQ
42,500. 00
0
0%
1.21T Market Cap
- P/E Ratio
350% Div Yield
87,006 Volume
2,433.78 Eps
42,500
Previous Close
Add Transaction
Day Range
41,450 42,800
Year Range
31,650 55,300
Want to track 195940 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

195940 closed today higher at ₩42,500, an increase of 0% from yesterday's close, completing a monthly decrease of -13.0879% or -₩6,400. Over the past 12 months, 195940 stock lost -13.0879%.
195940 is not paying dividends to its shareholders.
The last earnings report, released on Mar 24, 2025, exceeded the consensus estimates by 677.0037%. On average, the company has surpassed earnings expectations by 645.8884%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 2 different exchanges and in various currencies, with the primary listing on KOSDAQ (KRW).

195940 Chart

HK Inno N Corp (195940) FAQ

What is the stock price today?

The current price is ₩42,500.00.

On which exchange is it traded?

HK Inno N Corp is listed on KOSDAQ.

What is its stock symbol?

The ticker symbol is 195940.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 350%.

What is its market cap?

As of today, the market cap is 1.21T.

Has HK Inno N Corp ever had a stock split?

No, there has never been a stock split.

HK Inno N Corp Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Dal-Won Kwak CEO
KOSDAQ Exchange
- ISIN
KR Country
1,694 Employees
- Last Dividend
- Last Split
- IPO Date

Overview

HK inno.N Corporation is a prominent player in the pharmaceutical industry based in South Korea. Since its inception in 1984, the company has dedicated itself to the discovery, development, and distribution of a wide range of pharmaceutical products. With a strong footing in the medical field, it caters to various therapeutic areas including infections, anemia, diabetes, hypertension, dyslipidemia, gastrointestinal disorders, and certain types of cancers. Beyond its pharmaceutical ventures, HK inno.N has also expanded into the health and wellness sector, offering a variety of health supplements, functional foods, and beauty products under well-known brands. The company's international reach extends across Japan, Southeast Asia, Latin America, Europe, and the Middle East, signifying its global impact and commitment to improving health outcomes. Headquartered in Cheongju-si, South Korea, HK inno.N continues to innovate and contribute significantly to the global healthcare landscape.

Products and Services

  • Prescription Drugs:
  • HK inno.N offers an extensive portfolio of prescription medications tackling a spectrum of diseases. This includes treatments for both gram-positive and gram-negative bacterial infections, enterococcus faecium infections, vancomycin-resistant infections, acute bacterial sinusitis, bronchitis, pneumonia, anemia, hemodialysis, diabetes, hypertension, primary hypercholesterinemia, homozygous familial hypercholesterolemia, hypertension with dyslipidemia, GERD (Gastroesophageal Reflux Disease), EE (Erosive Esophagitis), NERD (Non-erosive Reflux Disease), GU (Gastric Ulcer), and H.Pylori infections, pleural mesothelioma, non-small cell lung cancer, and colorectal cancer.

  • Health and Beverage Products:
  • The company also plays a significant role in the wellness industry, producing hangover relief solutions, ready-to-drink beverages, health supplements, and health functional foods designed to enhance overall well-being.

  • Active Pharmaceutical Ingredients (APIs):
  • As a part of its extensive pharmaceutical services, HK inno.N provides high-quality active pharmaceutical ingredients, which serve as the crucial components for drug manufacturing and development.

  • Beauty Products:
  • Under the brands bewants, ScalpMed, and KLEDERMA RX, HK inno.N offers a variety of beauty products. These range from skincare items to treatments designed to address specific dermatological needs.

Contact Information

Address: 239 Osongsaengmyeong 2-ro, Cheongju-si, South Korea, 28158
Phone: 82 4 3249 8800